Paterson and seaberg were brought in to overlook and implement the sales of cc. And Mena hasn't brought anything in mate. How do we know the sales force behind cc alone aren't up to scratch? The CEO, chair, Turvey and Rowley can go as scapegoats and the buck stops with the chair and CEO, but we still have the sales team in general whom may be responsible for securing sales. Think of it as an each way bet where we have the plant and we have Mena. One has delivered but Mena hasn't. I honestly don't know but all the questions raised are credible I'm sure you would honestly agree. We just don't know which way forward is right
Reasons to keep holding Admedus shares, page-59
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |